These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7533681

  • 1. The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response--an in vivo model of Th2-like activity.
    Bundick RV, Craggs RI, Holness E.
    Clin Exp Immunol; 1995 Mar; 99(3):467-72. PubMed ID: 7533681
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth.
    Iwabuchi T, Maruyama T, Sei Y, Adachi K.
    J Dermatol Sci; 1995 Jan; 9(1):64-9. PubMed ID: 7537082
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Divergent effects of rapamycin on mouse and rat cells following mitogenic stimulation.
    Olivera DL, Kaplan JM, Newman-Tarr T, Ruggieri EV, Badger AM.
    Clin Immunol Immunopathol; 1993 Sep; 68(3):357-62. PubMed ID: 7690317
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cyclosporin A, FK506, rapamycin: the use of a quantitative analytic tool to discriminate immunosuppressive drug interactions.
    Kahan BD.
    J Am Soc Nephrol; 1992 Jun; 2(12 Suppl):S222-7. PubMed ID: 1379841
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
    Sharkey J, Butcher SP.
    Nature; 1994 Sep 22; 371(6495):336-9. PubMed ID: 7522303
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA, Bird IA, Almawi WY, Rieder MJ.
    J Pharmacol Exp Ther; 1997 Apr 22; 281(1):540-8. PubMed ID: 9103542
    [Abstract] [Full Text] [Related]

  • 17. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
    Duncan JI.
    J Invest Dermatol; 1994 Jan 22; 102(1):84-8. PubMed ID: 7507155
    [Abstract] [Full Text] [Related]

  • 18. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
    Rondeau E.
    Nephrologie; 1992 Jan 22; 13(3):137. PubMed ID: 1379348
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells.
    Pockley AG, Williams S, Reid SD, Bowles MJ.
    Biochem Soc Trans; 1995 Nov 22; 23(4):615S. PubMed ID: 8654800
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.